Market Cap
$68.42 Billion
USD as of Jan. 1, 2023
Company | Market Cap (USD) |
---|---|
![]() |
$304.61 B |
![]() |
$93.24 B |
![]() |
$79.53 B |
Marinomed Biotech AG | $76.72 B |
![]() |
$74.13 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
Moderna, Inc. is a biotechnology company, specialized in vaccine technology based on messenger RNA. It is notably famous for producing one of the first vaccines against Covid-19, and it is also developing and patenting other vaccine candidates for seasonal flu, HIV, the Nipah virus, and a second COVID-19 vaccine.
Moderna, Inc. has the following listings and related stock indices.
Stock: NASDAQ: MRNA
Stock: BMV: MRNA
Stock: Bovespa: M1RN34
Stock: FSX: 0QF
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.